1. Strasser T, Dondog N, EI Kholy AM, Ghargozloo R, Kalbian VV, Ogunbi O, Padmavati S, Stuart K, Dowd E, Bekessy A (1981) Report of a WHO international cooperative project. Bull WHO 59: 285–294
2. WHO Study Group (1988) Rheumatic fever and rheumatic heart disease. WHO technical report series No 764. Geneva, World Health Organization
3. Coburn AF, Moore LV (1939) The prophylactic use of sulfanilamide in streptococcal respiratory infections, with special reference to rheumatic fever. J Clin Invest 18: 147155
4. Stollerman GH, Rusoff JH (1952) Prophylaxis against group A streptococcal infections in rheumatic fever patients. JAMA 150: 1571–1575
5. Wood HF, Feinstein AR, Taranta A, Epstein JA, Simpson R (1964) Rheumatic fever in children and adolescents: a long term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. III. Comparative effectiveness of three prophylaxis regimens in preventing infections and rheumatic fever recurrences. Ann Intern Med 60 (suppl 5, pt II): 31–45